Pharmaron Beijing Co. Ltd. has acquired Aesica Pharmaceuticals’ Cramlington site from Recipharm.   The Cramlington site in Newcastle, UK, has an established history of cGMP manufacturing services for an array of active pharmaceutical ingredients (API), ranging from pilot scale to commercial metric ton scale. The Cramlington site has more than 100 cubic meter reactor commercial capacity and has been inspected and approved by the MHRA, FDA and other regulatory authorities.   This acquisition expan...